Vemurafenib: Background, Patterns of Resistance, and Strategies to Combat Resistance in Melanoma

Abstract

Introduction: Finding an effective treatment for metastatic melanoma has posed a series of challenges. Vemurafenib, a B-RAF tyrosine kinase inhibitor, has been one of the most successful medications to date in the treatment of metastatic melanoma. B-RAF is a serine/threonine kinase that is a part of the RAS-RAF-MEK-ERK signal transduction pathway, which… (More)

Topics

1 Figure or Table

Slides referencing similar topics